Could a drug combo make labor epidurals safer?
NCT ID NCT07506044
First seen Jun 25, 2026 · Last updated Aug 14, 2026 · Updated 3 times
Summary
This study will test whether adding two different doses of dexmedetomidine to the standard epidural drug bupivacaine can provide effective labor pain relief while using less bupivacaine. Researchers plan to enroll 140 women in early labor. The goal is to see if this approach reduces the total dose of bupivacaine needed and improves outcomes like pain scores and satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine added to bupivacaine
- What this could lead to
- If successful, this could help reduce the amount of bupivacaine needed for labor epidurals, potentially lowering side effects while still controlling pain.
- What could go wrong
- This is a small, early-stage study that hasn't started recruiting yet. Results may not apply to all women, and adding dexmedetomidine could cause unexpected side effects like drowsiness or low blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOTAL DOSE OF BUPIVACAINE ADMINISTERED DURING LABOR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine Menoufia University
RECRUITINGShebeen El Kom, 32511, Egypt